BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4456988)

  • 21. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.
    Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA
    Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphea: treatment of two clinical cases with cyclophenyl.
    Pachor ML; Nicolis F; Lunardi C; Bambara LM; Marchi G; Urbani G; Corrocher R; De Sandre G
    Clin Exp Rheumatol; 1987; 5(3):293-4. PubMed ID: 3427845
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment with cyclofenil in female patients not responding to clomifen (author's transl)].
    Horský J
    Cesk Gynekol; 1975 Aug; 40(7):544-6. PubMed ID: 1175242
    [No Abstract]   [Full Text] [Related]  

  • 24. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclofenil-induced hemolytic anemia in scleroderma.
    Russell ML; Schachter RK
    Acta Med Scand; 1981; 210(5):431-2. PubMed ID: 7336999
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of cyclofenil on atypical functional patterns of the hypothalamo-hypophyseo-thyroid axis encountered in postmenopausal women].
    Custro N; Scaffidi V; Patanella I
    Minerva Endocrinol; 1984; 9(1):37-45. PubMed ID: 6438465
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemolytic anemia during cyclofenil treatment of scleroderma.
    Wollheim FA; Ljunggren HO; Blom-Bülow B
    Acta Med Scand; 1981; 210(5):429-30. PubMed ID: 7039243
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormonal behavior during the menstrual cycle after administration of cyclofenil].
    Cismigiu F; Ruffié A
    J Gynecol Obstet Biol Reprod (Paris); 1974; 3(7):997-1014. PubMed ID: 4470780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sterility from hormonal causes and unexplained sterility. Treatment with cyclofenil. Double-blind controlled study].
    Cabau A; Krulik D; Reboul J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(1):96-101. PubMed ID: 2179398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of collagen and sulfated glycosaminoglycans by normal and scleroderma fibroblasts in culture, with and without addition of cyclofenil.
    Kjellström T; Malmquist J; Persson B
    Acta Med Scand; 1981; 210(1-2):125-8. PubMed ID: 7293821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of lactation by cyclofenil and bromocriptine.
    Schwarzenau E; Völker W
    Br J Obstet Gynaecol; 1984 Oct; 91(10):1053. PubMed ID: 6487568
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of low dosage of cyclofenil on oligoovulatory sterile women (author's transl)].
    Shinada T; Yokota Y; Negishi M; Nakamura J
    Nihon Funin Gakkai Zasshi; 1975 Jul; 20(3):41-4. PubMed ID: 1172476
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanism of action of cyclofenil in women].
    Cismigiu F; Ruffié A
    J Gynecol Obstet Biol Reprod (Paris); 1974 Mar; 3(2):253-4. PubMed ID: 4470570
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation by integrated thermography of the beneficial effect of cyclofenil in severe subcutaneous arterial insufficiency.
    Herbai G; Boczan J; Marsden NV; Ljunghall S
    Ups J Med Sci; 1985; 90(1):61-6. PubMed ID: 4002441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ondogyne in the treatment of ovarian sterility].
    Gelle P; Crepin G; Delahousse G; Decocq J; Platel C; Querleu D
    Lille Med; 1975 Apr; 20(4):433-7. PubMed ID: 1152598
    [No Abstract]   [Full Text] [Related]  

  • 36. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medium term treatment and prophylaxis of dysfunctional metrorrhagia in adolescence].
    Mossa B; Aleandri V; Novembri G; Morini A
    Minerva Ginecol; 1989 Oct; 41(10):503-7. PubMed ID: 2608196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of systemic sclerosis with topical PUVA.
    Morita A; Sakakibara S; Sakakibara N; Yamauchi R; Tsuji T
    J Rheumatol; 1995 Dec; 22(12):2361-5. PubMed ID: 8835578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.